Medefil Incorporated

Form 483 issued June 17, 2016 · Glendale Heights, Illinois

Inspection
Jun 6 – Jun 17, 2016
Observations
7
Pages
6
FEI number
3001677091

In short: On June 17, 2016, FDA issued a Form 483 with 7 observations to Medefil Incorporated in Glendale Heights, Illinois (FEI 3001677091) after an inspection that ran Jun 6 – Jun 17, 2016. The investigator was Laurimer Kuilan-Torres. Most observations concern production & process controls and materials.

At a glance

Observations span 4 systems, led by production & process controls.

Production & process controls2
Materials2
CAPA1
Quality system1
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedmes have not been established to control product that does not…

  2. 02

    Procedures for acceptance of incoming product have…

  3. 03

    Procedures to prevent contamination of equipment or product by substances that may have an adverse effect…

  4. 04

    Drug product containers were not clean arrd sterilized and processed to remove pyrogenic properties to assme…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Medefil Incorporated?

FDA listed 7 observations on this Form 483, mostly about production & process controls, materials and cAPA. The opening words of each observation are shown on this page.

Who inspected Medefil Incorporated?

Laurimer Kuilan-Torres is named on this Form 483, for the inspection of Jun 6 – Jun 17, 2016. Each investigator has a profile showing what they cite most.

When was Medefil Incorporated inspected by FDA?

The inspection ran Jun 6 – Jun 17, 2016, and the Form 483 is dated June 17, 2016.

How do I get the full Form 483 for Medefil Incorporated?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free